Knowledge, Attitudes and Practices Related to Medication, Antibiotics, and Vaccination among Public Service Population: National Survey Conducted in France

Medication, antibiotics, and immunization are three major and cost-effective medical interventions but their use is balanced. Knowledge, attitudes and practices (KAP) are a cornerstone. This retrospective study aims at analyzing KAP related to these concerns among the public service population in order to establish the basis for the implementation of selective preventive actions. From a cross-sectional anonymous online questionnaire-based survey among the insurees of a French mutual organization (Union Prévention Santé pour la Fonction publique, UROPS), 33 questions related to medication, antibiotics and vaccination were extracted to evaluate KAP. New variables were constituted: levels of knowledge, antibiotic misuse, proactive behavior and vaccinophobia. Multiple correspondence analysis was performed to identify respondents’ homogenous groups. In addition, bivariate statistical comparisons were provided and logistic regressions were carried out to identify determinants of these new variables. Public service population (workers and retired) were highly exposed to polymedication (8.7% vs. 24.4%, p < 0.0001), hypnotics overtake (24.3% vs. 18.4%, p < 0.0001), and misuse antibiotics (33.2% vs. 22.6%, p < 0.0001) despite good levels of knowledge. Proportions of vaccinophobia was low (0.8% vs. 1.7%, p < 0.0001). However, workers have different KAP than retired, without shared determinants in the 3 health domains studied. Respondents were proactive (85.8% vs. 81.6%, p < 0.0001), used multiple sources of trustworthy information and seems to be ready for the delegation of health tasks. Thus, preventive actions related to antibiotics and polymedication should be a priority in vaccination education for mutual organizations such as UROPS. Studying their insurees longitudinally could be interesting to highlight the impact of selective prevention on behaviors, through trusted health professionals (general practitioners, pharmacists…).

[1]  E. Clays,et al.  Polypharmacy and Health-Related Quality of Life/Psychological Distress Among Patients With Chronic Disease , 2022, Preventing chronic disease.

[2]  Muhamad S. Aljeaidi,et al.  Polypharmacy and trajectories of health-related quality of life in older adults: an Australian cohort study , 2022, Quality of Life Research.

[3]  R. Rizzoli,et al.  Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH , 2022, BMJ Open.

[4]  B. Sites,et al.  Anxiolytic and sedative polypharmacy among US opioid users: a cross-sectional study , 2022, Regional Anesthesia & Pain Medicine.

[5]  Toshiko Yamamoto,et al.  Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city—Itoigawa study , 2022, Neurological Sciences.

[6]  Z. Hildon,et al.  The Associations between Poor Antibiotic and Antimicrobial Resistance Knowledge and Inappropriate Antibiotic Use in the General Population Are Modified by Age , 2021, Antibiotics.

[7]  T. Prell,et al.  Factors Influencing Self-Reported Medication Use in the Survey of Health Aging and Retirement in Europe (SHARE) Dataset , 2021, Healthcare.

[8]  C. Sprung,et al.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.

[9]  W. Montelpare,et al.  Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging , 2021, International journal of environmental research and public health.

[10]  A. Ströhle,et al.  COVID-19 vaccine hesitancy and related fears and anxiety , 2021, International Immunopharmacology.

[11]  C. Sherbourne,et al.  A Consensus-Based Checklist for Reporting of Survey Studies (CROSS) , 2021, Journal of General Internal Medicine.

[12]  B. Kochar,et al.  Emerging approaches to polypharmacy among older adults , 2021, Nature Aging.

[13]  C. Tzourio,et al.  Acceptance of a Covid-19 vaccine is associated with ability to detect fake news and health literacy , 2021, Journal of public health.

[14]  R. Geneau Pulling health promotion and chronic disease prevention from the margins of the global public health agenda-again. , 2021, Health promotion and chronic disease prevention in Canada : research, policy and practice.

[15]  R. Rappuoli,et al.  The role of vaccines in combatting antimicrobial resistance , 2021, Nature Reviews Microbiology.

[16]  Amos Etzioni,et al.  Adherence to Immunization: Rebuttal of Vaccine Hesitancy , 2020, Acta Haematologica.

[17]  N. Rodondi,et al.  What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey , 2020, BMC Geriatrics.

[18]  E. Botelho-Nevers,et al.  Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic , 2020, Vaccine.

[19]  O. Okan,et al.  COVID-19: health literacy is an underestimated problem , 2020, The Lancet Public Health.

[20]  S. Voidăzan,et al.  Knowledge, Attitudes And Practices Regarding The Use Of Antibiotics. Study On The General Population Of Mureş County, Romania , 2019, Infection and drug resistance.

[21]  Satya Sivaraman,et al.  Communication strategies for improving public awareness on appropriate antibiotic use: Bridging a vital gap for action on antibiotic resistance , 2019, Journal of family medicine and primary care.

[22]  Joon-Hee Lee Perspectives towards antibiotic resistance: from molecules to population , 2019, Journal of Microbiology.

[23]  C. Stålsby Lundborg,et al.  Drivers of Irrational Use of Antibiotics in Europe , 2018, International journal of environmental research and public health.

[24]  P. Chauvin,et al.  Who self-medicates? Results from structural equation modeling in the Greater Paris area, France , 2018, PloS one.

[25]  N. Sartorius,et al.  Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia , 2018, Journal of clinical psychopharmacology.

[26]  P. Kardas,et al.  Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. , 2018, Archives of gerontology and geriatrics.

[27]  B. Golomb,et al.  International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action , 2018, Drugs & Aging.

[28]  C. Clements,et al.  Relative toxicity of benzodiazepines and hypnotics commonly used for self-poisoning: An epidemiological study of fatal toxicity and case fatality , 2018, Journal of psychopharmacology.

[29]  D. Stewart,et al.  Benzodiazepine prescriptions and falls in older men and women , 2018 .

[30]  W. Hryniewicz,et al.  Surveys of public knowledge and attitudes with regard to antibiotics in Poland: Did the European Antibiotic Awareness Day campaigns change attitudes? , 2017, PloS one.

[31]  M. Mittelmark,et al.  The Handbook of Salutogenesis , 2017 .

[32]  P. Denormandie,et al.  Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France , 2017, European Journal of Clinical Pharmacology.

[33]  W. Welfare,et al.  Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization. , 2016, The Journal of hospital infection.

[34]  S. Waters Suicide voices: testimonies of trauma in the French workplace , 2016, Medical Humanities.

[35]  C. Pulcini,et al.  Acceptability of antibiotic stewardship measures in primary care. , 2016, Medecine et maladies infectieuses.

[36]  S. Mohile,et al.  Polypharmacy and potentially inappropriate medication use in geriatric oncology. , 2016, Journal of geriatric oncology.

[37]  Eileen M. Crimmins,et al.  Lifespan and Healthspan: Past, Present, and Promise. , 2015, The Gerontologist.

[38]  J. Chastang,et al.  Working conditions and psychotropic drug use: cross-sectional and prospective results from the French national SIP study. , 2015, Journal of psychiatric research.

[39]  C. L. Ventola,et al.  The antibiotic resistance crisis: part 2: management strategies and new agents. , 2015, P & T : a peer-reviewed journal for formulary management.

[40]  Onkar C. Swami,et al.  Strategies to combat antimicrobial resistance. , 2014, Journal of clinical and diagnostic research : JCDR.

[41]  E. C. Harris,et al.  The role of mental health problems and common psychotropic drug treatments in accidental injury at work: a case–control study , 2014, Occupational and Environmental Medicine.

[42]  H. Burr,et al.  Does good leadership buffer effects of high emotional demands at work on risk of antidepressant treatment? A prospective study from two Nordic countries , 2014, Social Psychiatry and Psychiatric Epidemiology.

[43]  Liang-Jen Wang,et al.  Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey. , 2014, Psychiatric services.

[44]  H. Allahverdipour,et al.  Predictors of Self-Medication Behavior: A Systematic Review , 2014, Iranian journal of public health.

[45]  Hans-Peter Grossart,et al.  The multifaceted roles of antibiotics and antibiotic resistance in nature , 2013, Front. Microbiol..

[46]  S. Rosman,et al.  Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study , 2011, BMC family practice.

[47]  Gilles Jeannot,et al.  The Development and Current Features of the French Civil Service System , 2011 .

[48]  H. Burr,et al.  Person-related work and incident use of antidepressants: relations and mediating factors from the Danish work environment cohort study. , 2010, Scandinavian journal of work, environment & health.

[49]  R. Rugulies,et al.  Job stress and the use of antidepressant medicine: a 3.5-year follow-up study among Danish employees , 2010, Occupational and Environmental Medicine.

[50]  S. L. C. da Silva,et al.  Association between drug prescribing and quality of life in primary care , 2010, Pharmacy World & Science.

[51]  É. Lavigne,et al.  Psychosocial work environment, interpersonal violence at work and psychotropic drug use among correctional officers. , 2010, International journal of law and psychiatry.

[52]  E. Agerbo,et al.  Psychosocial work environment and antidepressant medication: a prospective cohort study , 2009, BMC public health.

[53]  P. Böelle,et al.  Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002–2007 , 2009, PLoS medicine.

[54]  J. Fincham Response Rates and Responsiveness for Surveys, Standards, and the Journal , 2008, American Journal of Pharmaceutical Education.

[55]  C. Mcnulty,et al.  Antimicrobial Drugs in the Home, United Kingdom , 2006, Emerging infectious diseases.

[56]  C. Potter Hesitancy , 2005 .

[57]  J. Lépine,et al.  The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in Europe , 2004, Acta psychiatrica Scandinavica. Supplementum.

[58]  R. Kessler,et al.  Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.

[59]  R. Gordon An operational classification of disease prevention. , 1983, Public health reports.